PodcastIntel
Sign in Get Started Free
Rand Radio
Rand Radio

Allowing Biosimilars Will Change the Game

Jan 10, 2026 · 0m
AI Summary
  • Americans pay more for healthcare than any nation with worse health outcomes due to excessive bureaucracy and regulation that stifles competition
  • Sen. Rand Paul authored legislation to fast-track biosimilars (generic biologics) through FDA approval, arguing science proves they're equivalent to brand-name drugs without requiring extensive clinical studies
  • FDA implemented Paul's reforms to reduce drug costs and increase affordability without sacrificing medication quality

More from Rand Radio

View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Rand Radio and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →